USPTO serial 99685145
TRI-OFFENSE
Reviewed by CopyMark Law Group
Status 688Notice of Allowance
- Filing date
- Status date
- Registration date
- —
- Examiner
- DANG, PETER T
- Law office
- INTENT TO USE SECTION
What this means
The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.
Need help with TRI-OFFENSE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,545*
Plus Government fees of $750
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
San Diego, CA, US
San Diego, CA, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Alicia M. Passerin
Alicia M. Passerin Leech Tishman Fuscaldo & Lampl525 William Penn Place, 28th FloorPittsburgh, PA 15219United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Medicinal preparations for the treatment and prevention of cancer and infectious diseases; Pharmaceutical preparations for the treatment of of infectious diseases; Pharmaceutical preparations for the prevention of infectious diseases; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical preparations for the prevention of cancer; Biological preparations for the prevention and treatment of cancer and infectious diseases; Vaccines | ACTIVE | — |
| 009 | Downloadable digital publications, namely, downloadable brochures, booklets, and journal articles in the field of cancer and infectious diseases therapy | ACTIVE | — |
| 016 | Printed publications, namely, brochures, booklets, and journal articles in the field of cancer and infectious diseases therapy | ACTIVE | — |
| 042 | Providing information about medical and scientific research via a website; Medical and scientific research in the field of cancer treatment; Product development in the field of cancer and infectious diseases therapy | ACTIVE | — |
| 044 | Providing medical information via a website | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by ImmunityBio, Inc.
- Other trademarks owned by ImmunityBio, Inc.
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 016
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named TRI-OFFENSE
- Prosecution event NOAM explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 27, 2026 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Sep 1, 2026 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Sep 1, 2026 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 26, 2026 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Aug 6, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 5, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 5, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 5, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 8, 2026 | GEAN | NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED | — |
| Jul 8, 2026 | GEAP | EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED | — |
| Jul 8, 2026 | EPEN | COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY | — |
| Jul 8, 2026 | CPEA | EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED | — |
| Jul 6, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 2, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 5, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Mar 5, 2026 | NWAP | NEW APPLICATION ENTERED | — |